Larry Liu

I invest in early-stage Medtech & Healthtech ventures building the next-generation interventional, diagnostic, and AI-enabled healthcare technologies. My focus is on solving clearly defined unmet clinical need with durable product differentiation, particularly in platforms and devices that improve precision, outcomes, and scalability. Portfolio includes: ● Madison Scientific - Hydrocephalus SmartShunt ● ConKay Medical - Tricuspid Annular Repair ● Neurava - Epilepsy Seizure Prevention ● MyBackHub - AI-Powered Scoliosis Care ● NyquistAI - Regulatory & Clinical Intelligence ● Hubly Surgical - Spinal & Cranial Access

MedTech Innovator is the world's largest accelerator for early- and mid-stage medical device, diagnostic, and digital health startups, selecting top talent like the 2025 cohort's 64 companies (top 4% global acceptance rate)

We are a premier angel investment group that provides early-stage capital (Pre-Seed, Seed, and Follow-On Investment) and deep domain mentorship to disruptive startups across the med-tech, digital health, and biotechnology sectors.

We are an early stage medical device company advancing solutions to treat valvular regurgitation in patients with progressive heart failure.

We are a ready-to-use cloud-based AI solution that provides data aggregation, workflow automation and predictive analytics to support strategic decision making in regulatory, R&D, and commercialization for the life sciences industry.

We are a cranial and orthopedic platform drilling solution that focuses on modernizing three verticals: bedside intracranial access, elective neurosurgeries, and elective orthopedic surgeries. Our mission is to improve patient outcomes and increase quality of care for surgical procedures, inclusively, across standard and underserved settings.

Our mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials.

We are building a truly differentiated digital surgery ecosystem to change the standard of care for generations to come. Our vision is to make medical interventions smarter, less invasive and more personalized..

We were acquired by Johnson & Johnson (NYSE: JNJ) on December 20, 2019.

We are building a digital surgery platform that combines robotics, advanced visualization, advanced instrumentation, data analytics and connectivity.

We are a boutique consulting firm that offer regulatory services to med-tech companies to help them get innovative products to market and maintain compliance cost-effectively. We cleared the first Deep-Learning 510(k) for medical application with FDA in early 2017 and became part of Verb Surgical to lead the Joint Venture's regulatory strategy & implementation.

Stanford Ignite is an on-campus, part-time program on innovation and entrepreneurship at the Stanford Graduate School of Business. It is taught by prominent Stanford GSB faculty with focuses on core business skills and entrepreneurship. The program is led by Yossi Feinberg, the Senior Associate Dean for Academic Affairs of the MBA and MSx programs.